MAP BIOPHARMA LIMITED - Profile & Financials

Accounts Submitted 2 Jan 2024

Confirmation Statement Submitted

Net assets £1.00

Total assets £1.00

Total Liabilities £0.00

Charges 1

1 outstanding

AI Analysis

Analyze director networks, ownership patterns, and company connections

CompanyTrack AI can make mistakes. Check important info.

Contact & Details

Contact

Update Details

Registered Address

Upper Pendril Court Ermine Street North Papworth Cambridge CB23 3UY United Kingdom

Credit Report

Discover MAP BIOPHARMA LIMITED's Credit Score, limit, and payment likelihood.

Mutual Companies

See All Mutual Companies

Financials

Period 1 Jan → 31 Dec 2023

Type Total Exemption Full

Next accounts 31 December 2024

Due by 30 September 2025 9 months

Net Assets, Total Assets & Total Liabilities (2023–2023)

Cash in Bank

£1.00

Net Assets

£1.00

Total Liabilities

N/A

Turnover

N/A

Employees

N/A

Debt Ratio

N/A

Financial History

Revenue, profit, EBITDA and key financial figures

	2023 Dec Year End
P&L
Revenue	£142.3M
Gross Profit	£48.2M
Operating Profit	£22.4M
Net Profit	£18.1M
EBITDA	£31.5M
Assets
Cash	£24.7M
Total Assets	£89.4M
Liabilities
Total Liabilities	£45.2M
Key Metrics
Employees	1,247

Latest Revenue

£142.3M

Latest EBITDA

£31.5M

Cash Position

£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

2 active 3 resigned

Show resigned officers

						Status
Christian Anthony Harry Hill	Director	British	England	50	3 Mar 2022	Active
Sebastian Murphy	Director	British	United Kingdom	42	19 Jan 2024	Active

Shareholders

Shareholders (0)

No shareholder data available

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Map Life Sciences Limited

United Kingdom

Active

Notified 3 Mar 2022

Nature of Control

Ownership Of Shares 75 To 100 Percent
Voting Rights 75 To 100 Percent
Right To Appoint And Remove Directors

See All Controllers

Group Structure

MAP LIFE SCIENCES LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

MUSTANG BIDCO LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

MUSTANG MIDCO LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

MUSTANG TOPCO LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

KESTER CAPITAL III GP LLP united kingdom voting rights 25 to 50 percent limited liability partnership, right to share surplus assets 25 to 50 percent limited liability partnership

GCP EUROPE GP1 LTD united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

GCP EUROPE GP2 LTD united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

KESTER CAPITAL LLP united kingdom

MAP BIOPHARMA LIMITED Current Company

Charges

1 outstanding

Documents

Company Filings

Date	Category	Description	Document
7 May 2024	Gazette	Gazette Dissolved Voluntary	View(1 page)
20 Feb 2024	Gazette	Gazette Notice Voluntary	View(1 page)
12 Feb 2024	Dissolution	Dissolution Application Strike Off Company	View(1 page)
25 Jan 2024	Officers	Appointment of Mr Sebastian Murphy as director on 2024-01-19	View(2 pages)
2 Jan 2024	Accounts	Annual accounts made up to 2023-03-31	View(2 pages)